Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 134.10
-5.19 (-3.73%)
Feb 2, 2026, 2:00 PM IST
Suven Life Sciences Employees
Suven Life Sciences had 138 employees as of March 31, 2025. The number of employees decreased by 3 or -2.13% compared to the previous year.
Employees
138
Change (1Y)
-3
Growth (1Y)
-2.13%
Revenue / Employee
511.71K INR
Profits / Employee
-19.91M INR
Market Cap
32.31B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 138 | -3 | -2.13% |
| Mar 31, 2024 | 141 | 10 | 7.63% |
| Mar 31, 2023 | 131 | 14 | 11.97% |
| Mar 31, 2022 | 117 | -13 | -10.00% |
| Mar 31, 2021 | 130 | -12 | -8.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Akums Drugs and Pharmaceuticals | 7,536 |
| Indoco Remedies | 6,000 |
| Strides Pharma Science | 3,301 |
| Aarti Pharmalabs | 2,162 |
| Solara Active Pharma Sciences | 1,775 |
| Windlas Biotech | 1,346 |
| RPG Life Sciences | 1,331 |
| Orchid Pharma | 736 |
Suven Life Sciences News
- 7 weeks ago - Suven Life Sciences achieves 100% enrollment for Phase-2b Trial of Ropanicant for major depressive disorder - Business Upturn
- 1 year ago - Suven Life Sciences shares surge over 8% after clinical trial update - Business Upturn
- 1 year ago - Suven Life Sciences initiates Phase-1 clinical trial for SUVN-I6107 - Business Upturn